Literature DB >> 11731057

"Stable" inertial cavitation.

C C Church1, E L Carstensen.   

Abstract

This note compares theoretical predictions of pressure waves scattered by free gas bubbles with recent acoustical determinations of cavitation thresholds for individual microbubbles of the surfactant-stabilized contrast agent Sonazoid(R). The results indicate that surfactant-coated microbubbles undergo "stable" (i.e., repetitive) inertial cavitation above a threshold of 0.3 to 0.4 MPa at 2.5 MHz, and that irreversible postcollapse bubble fragmentation usually requires much higher pressures (approximately 1.5 MPa). Adverse bioeffects can be expected in vivo far below these fragmentation pressures when contrast agents are present. With diagnostically relevant exposures, the threshold for the generation of petechiae in skeletal muscle is approximately 0.6 MPa at 2.5 MHz.

Mesh:

Substances:

Year:  2001        PMID: 11731057     DOI: 10.1016/s0301-5629(01)00441-0

Source DB:  PubMed          Journal:  Ultrasound Med Biol        ISSN: 0301-5629            Impact factor:   2.998


  9 in total

1.  Ultrasonic contrast agent shell rupture detected by inertial cavitation and rebound signals.

Authors:  Azzdine Y Ammi; Robin O Cleveland; Jonathan Mamou; Grace I Wang; S Lori Bridal; William D O'Brien
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2006-01       Impact factor: 2.725

2.  Passive cavitation imaging with ultrasound arrays.

Authors:  Vasant A Salgaonkar; Saurabh Datta; Christy K Holland; T Douglas Mast
Journal:  J Acoust Soc Am       Date:  2009-12       Impact factor: 1.840

Review 3.  Molecular imaging of disease with targeted contrast ultrasound imaging.

Authors:  Yoichi Inaba; Jonathan R Lindner
Journal:  Transl Res       Date:  2012-01-04       Impact factor: 7.012

4.  Cavitation properties of block copolymer stabilized phase-shift nanoemulsions used as drug carriers.

Authors:  Natalya Rapoport; Douglas A Christensen; Anne M Kennedy; Kweon-Ho Nam
Journal:  Ultrasound Med Biol       Date:  2010-02-04       Impact factor: 2.998

5.  The role of primary and secondary delays in the effective resonance frequency of acoustically interacting microbubbles.

Authors:  Hossein Haghi; Michael C Kolios
Journal:  Ultrason Sonochem       Date:  2022-05-13       Impact factor: 9.336

6.  Development and evaluation of an ultrasound-triggered microbubble combined transarterial chemoembolization (TACE) formulation on rabbit VX2 liver cancer model.

Authors:  Doyeon Kim; Jae Hwan Lee; Hyungwon Moon; Minkyu Seo; Hyounkoo Han; Hongkeun Yoo; Howon Seo; Jingu Lee; Sujung Hong; Pilhan Kim; Hak Jong Lee; Jin Wook Chung; Hyuncheol Kim
Journal:  Theranostics       Date:  2021-01-01       Impact factor: 11.556

7.  Improving temporal stability of stable cavitation activity of circulating microbubbles using a closed-loop controller based on pulse-length regulation.

Authors:  Chunjie Tan; Bo Yan; Tao Han; Alfred C H Yu; Peng Qin
Journal:  Ultrason Sonochem       Date:  2021-12-20       Impact factor: 7.491

8.  Ultrasound- and Microbubble-Assisted Gemcitabine Delivery to Pancreatic Cancer Cells.

Authors:  Tormod Bjånes; Spiros Kotopoulis; Elisa Thodesen Murvold; Tina Kamčeva; Bjørn Tore Gjertsen; Odd Helge Gilja; Jan Schjøtt; Bettina Riedel; Emmet McCormack
Journal:  Pharmaceutics       Date:  2020-02-07       Impact factor: 6.321

9.  SonoVue® vs. Sonazoid™ vs. Optison™: Which Bubble Is Best for Low-Intensity Sonoporation of Pancreatic Ductal Adenocarcinoma?

Authors:  Spiros Kotopoulis; Mihaela Popa; Mireia Mayoral Safont; Elisa Murvold; Ragnhild Haugse; Anika Langer; Georg Dimcevski; Christina Lam; Tormod Bjånes; Odd Helge Gilja; Emmet Mc Cormack
Journal:  Pharmaceutics       Date:  2022-01-01       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.